News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis
Vincent Rajkumar/X
May 12, 2025, 10:53

Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared an article on X:

“Solitary plasmacytoma.

One lesion, but 3 possible entities with differing prognosis in the differential diagnosis.

Outcomes and management.”

Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes.

Authors: Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, Moritz Binder, Francis K. Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L. Fonder, Morie A. Gertz, Wilson Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar.

You can read the Full Article on Journal of Blood Advances.

Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis

More posts featuring Vincent Rajkumar.

Amie L Fonder Angela Dispenzieri cancer Charalampos Charalampous David Dingli diagnosis fight against cancer Francis K. Buadi Global fight against cancer Jean-Sebastien Claveau Joselle Cook Martha Q Lacy Mayo Clinic Miriam A Hobbs Morie A Gertz Moritz Binder Nelson Leung OncoDaily Oncology Prashant Kapoor prognosis Rahma Warsame Robert A. Kyle Rochester S Vincent Rajkumar Shaji K. Kumar Solitary Plasmacytoma Suzanne R Hayman Taxiarchis Kourelis Vincent Rajkumar Wilson Gonsalves Yi L. Hwa Yi Lin
Special Coverage
Oncolibrary
Jul 1, 2025, 12:44
MASCC 2025 Highlights: StrataXRT Prevents Severe Radiation Dermatitis in Large-Breasted Women Undergoing Prone Breast Radiotherapy
Blog
Jul 1, 2025, 10:46
INTERACT-EUROPE 100 Has Launched a New Round of Recruitment - European Cancer Organisation
Societies
Jul 1, 2025, 10:32
25 Posts Not To Miss From MASCC 2025
Blog
Jul 1, 2025, 10:30
Alina Comanescu: Urgent Call to Action - Don't Let Cancer Slip Off the EU Agenda
Blog
Jul 1, 2025, 10:16
Survivor Cindy Pursues Nursing in Ghana Fifteen Years After Kidney Cancer Diagnosis - World Child Cancer
Blog
Jul 1, 2025, 10:07
Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe - EORTC
Blog
Jul 1, 2025, 09:57
Gevorg Tamamyan: To Me, MD Anderson Has Always Meant Dr. Kantarjian
Career
Jul 1, 2025, 09:56
Sidney Chahonyo is Breaking Barriers as the First Survivor on the Board of Childhood Cancer International
Blog
Jul 1, 2025, 09:34
Jasmine Kamboj: Congratulating the New Co-Leads of the Community of Practice Policy
Dialogues
Jul 1, 2025, 09:27
Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer
Blog
Jul 1, 2025, 09:25
Alexandre Chan's Final Reflection on MASCC 2025
Dialogues
Jul 1, 2025, 09:21
Women Leaders in Oncology: Nina Mojas on GSK’s Oncology Growth and Innovation Strategy